The cellular FLICE inhibitory protein (c-FLIP) is an endogenous inhibitor of the caspase-8 proapoptotic signaling pathway downstream of death receptors. Recent evidence indicates that the long form of c-FLIP (c-FLIP L ) is required for proliferation and effector T-cell development. However, the role of c-FLIP L in triggering autoimmunity has not been carefully analyzed. We now report that c-FLIP L transgenic (Tg) mice develop splenomegaly, lymphadenopathy, multiorgan infiltration, high titers of autoantibodies, and proliferative glomerulonephritis with immune complex deposition in a strain-dependent manner. The development of autoimmunity requires CD4 þ T cells and may result from impaired thymic selection. At the molecular level, c-FLIP L overexpression inhibits the f chain-associated protein tyrosine kinase of 70 kDa (ZAP-70) activation, thus impairing the signaling pathway derived from ZAP-70 required for thymic selection. Therefore, we have identified c-FLIP L as a susceptibility factor under the influence of epistatic modifiers for the development of autoimmunity.
One of the fundamental properties of the immune system is to distinguish self from non-self, which is central to its ability to protect against pathogens and, at the same time, maintain non-responsiveness to self. This property is established during lymphocyte development within generative lymphoid organs (central tolerance) or in the secondary lymphoid organs (peripheral tolerance). 1, 2 Much attention has been devoted to studies understanding the cellular and molecular basis of tolerance mechanisms, as well as the situations under which these mechanisms breakdown leading to autoimmune disease. The understanding of these complex biological processes at molecular levels has been facilitated by various transgenic (Tg) and knockout mouse strains, as well as by strains with spontaneous mutations that develop an autoimmune phenotype.
Signaling derived from the T-cell receptor (TCR) is required for thymocyte development and thymic selection. The selection of the T-cell repertoire, which is essential for establishing self/non-self discrimination of immune recognition, occurs in the thymus, and is based on the binding strength (affinity) of the TCR for peptide-MHC complexes that are presented by epithelial and bone marrow-derived antigen-presenting cells. Thymocytes that bind self-peptide-MHC complexes too strongly undergo apoptosis and fail to enter the mature T-cell pool (a process known as negative selection). The thymocytes that express low-affinity TCRs that are specific for self-peptide-MHC complexes, are the only ones to survive (in a process known as positive selection) and migrate out of the thymus. 1, 2 Recent studies indicated that a number of TCR signaling molecules are involved in both positive and negative selection in the thymus. 3 A defect in thymic selection results in autoimmunity. 2, 3 Cellular FLICE inhibitory protein (c-FLIP) is an endogenous inhibitor of the Fas-associated death domain protein (FADD)-caspase-8 proapoptotic signaling pathway downstream of death receptors. 4 The 55-kDa long form of c-FLIP (c-FLIP L ) is structurally similar to caspase-8 and caspase-10, as it contains two death effector domains (DEDs) and a caspaselike domain. However, this caspase-like domain lacks residues that are important for the catalytic activity of caspase-8. 5 Thus, c-FLIP can inhibit death receptor-mediated caspase-8 activation. 4 Intriguingly, when expressed at a low concentration, c-FLIP L can act as an activator of pro-caspase-8, possibly by heterodimerizing with caspase-8. 6 It appears that the expression levels of c-FLIP L may be crucial for its biological functions. Although mice deficient for both c-FLIP L and c-FLIP S in T cells show severe defects in thymocyte development, 7, 8 c-FLIP L deficiency in T cells does not disturb thymocyte development. Rather, c-FLIP L may mediate T-cell activation and proliferation through an unidentified mechanism. 7 c-FLIP L may, therefore, serve as a modulator between apoptotic and proliferative responses after TCR stimulation. 9 However, it has not been shown that overexpression of c-FLIP L in the T-cell lineage triggers autoimmunity.
In this report, we describe that mice overexpressing c-FLIP L in T cells in a BALB/c background spontaneously develop an autoimmune lymphoproliferative syndrome showing features of systemic lupus erythematosus (SLE) in humans. In contrast, c-FLIP L Tg mice in the C57BL/6 (B6) background maintain tolerance to nuclear antigens, and are resistant to the development of lupus-like disease. The development of lupus-like disease in c-FLIP L Tg mice is because of altered thymic selection in the BALB/c background by interfering with the signaling pathway derived from the z chain-associated protein tyrosine kinase of 70 kDa (ZAP-70).
Results c-FLIP L transgene product is specifically expressed in T cells but not in B cells and dendritic cells. c-FLIP L was expressed transgenically in the T-cell compartment as reported earlier. 6 Briefly, FLAG-tagged mouse FLIP L cDNA was inserted into a target vector containing the b-globin promoter and a downstream human CD2 locus enhancer element. To confirm that the c-FLIP L transgene product is not expressed in other cell types, such as B cells and dendritic cells (DCs), c-FLIP L transgene expression in thymocytes, splenic T cells, B cells, and DCs of BALB/c and B6 backgrounds was detected using anti-FLAG Ab. As shown in Supplementary Figure 1 , the c-FLIP L transgene product was detected only in thymocytes and T cells but not in B cells and DCs from BALB/c and B6 c-FLIP L Tg mice, neither in their non-Tg littermate controls (NLCs), and was comparable between BALB/c and B6 strains. Consistent with the earlier report, 6 in addition to the p55 kDa form of c-FLIP L , an additional 43 kDa cleavage product of Tg c-FLIP L was found in both thymocytes and splenic T cells from BALB/c and B6 c-FLIP L Tg mice (Supplementary Figure S1) . BALB/c but not B6 c-FLIP L Tg mice spontaneously develop lupus-like disease. c-FLIP L Tg mice in a B6 background (B6 c-FLIP L Tg mice) do not develop any autoimmune disease. 6 In accordance with these data, we did not observe any sign of autoimmunity in B6 c-FLIP L Tg mice until 10 months of age (data not shown). The absence of auto-antibodies (auto-Abs) or spontaneous autoimmune disease suggested that additional genetic or environmental factors might be necessary to trigger autoimmunity in these susceptible mice. To analyze the contribution of genetic background and modifier loci to the development of autoimmunity, we backcrossed these mice to a BALB/c background for 14 generations. Although new-born BALB/c c-FLIP L Tg mice seemed normal, these mice were smaller in size than NLCs when they grew up to 3-5 weeks of age ( Figure 1a) . Almost all BALB/c c-FLIP L Tg mice developed a generalized lymphadenopathy and splenomegaly starting from 3 weeks of age and being evident by 6-10 weeks of age, of which 20-30% BALB/c c-FLIP L Tg mice showed diarrhea ( Figure 1a ). In contrast, there was an agedependent severe thymic atrophy in these mice (Figure 1b) . The spleens from 7-week-old BALB/c c-FLIP L Tg mice showed that there was a significant increase in lymphoid cells, which formed aggregates in the white pulp and spread into the red pulp, filling in the cords and sinuses. PNA staining revealed a spontaneous germinal center (GC) formation in BALB/c c-FLIP L Tg mice but not in NLCs (Figure 1b) .
Histological analysis showed evident lymphocytic infiltration in the portal tracts of the liver, heart valves, peribronchiolar spaces of the lung, and the mucosa and submucosa of the stomach and the large and small intestines. Salivary glands from BALB/c c-FLIP L Tg mice also showed dense lymphocyte infiltration (Figure 1c ). Kidney sections from BALB/c c-FLIP L Tg mice showed a diffuse proliferative glomerulonephritis in BALB/c c-FLIP L Tg mice, characterized by enlarged glomeruli, loss of Bowman's capsule space, thickening of the mesangium, and hypercellularity. Immunofluorescence staining showed IgG and C3 deposition in glomeruli (Figure 1d -e). Serological analysis showed that BALB/c c-FLIP L Tg mice had markedly elevated levels of antinuclear, anti-ssDNA, and anti-dsDNA Abs, whereas B6 c-FLIP L Tg mice were negative for these auto-Abs (Figure 1f ). Taken together, our results suggest that overexpressing c-FLIP L in T cells leads to the development of systemic lupus-like disease, which was contingent on the BALB/c background. The susceptible c-FLIP L Tg background requires the host background to trigger autoimmunity.
c-FLIP L overexpression leads to impaired thymic selection in a BALB/c background. The difference observed in susceptibility to disease development in BALB/c c-FLIP L Tg mice as compared with B6 c-FLIP L Tg mice may result from the differences in T-cell development in these two strains. Development of autoimmunity could be because of the breakdown of self-tolerance in the thymus and/or changes in the activation thresholds of peripheral lymphocytes. It has been documented that thymocyte development is not altered in B6 c-FLIP L Tg mice. 6 To analyze whether a defect in T-cell development might be responsible for disease development in BALB/c mice overexpressing c-FLIP L in T cells, we stained thymocytes from BALB/c c-FLIP L Tg and NLCs (1 week of age) with fluorescence-conjugated Abs against CD4 and CD8 in combination with CD25 and CD44 to define thymocyte development. BALB/c c-FLIP L Tg thymocytes developed successfully from the double-negative (DN) to the doublepositive (DP) stage (data not shown). Although total thymocyte numbers in BALB/c c-FLIP L Tg mice were normal at 1 week of age, there were significant reductions in the percentages and absolute numbers of CD4 singlepositive (SP) thymocyte populations ( Figure 2a ; Table 1 ), suggesting that their differentiation from DP to CD4 SP thymocytes was compromised. At 7 weeks of age, the total thymocyte numbers of BALB/c c-FLIP L Tg mice were reduced to about 20% of that of NLCs. The reduced thymocyte numbers were the result of smaller DP (31% of control) and 
CD4
þ SP (65% of control) populations ( Figure 2a ; Table 1 ). The involuted thymus in older BALB/c c-FLIP L Tg mice may be secondary to stress. In sharp contrast, B6 c-FLIP L Tg mice showed normal distributions of DP and SP thymocytes (Supplementary Figure S2a) and no thymic atrophy (data not shown). These data suggest that overexpression of c-FLIP L impairs thymocyte development in a straindependent manner.
To obtain further insight into the mechanism underlying altered thymic development, we analyzed whether the reduction in the numbers of CD4 SP thymocytes was caused by a defect in positive selection. During positive selection, CD69 expression is induced, and CD5 is upregulated. 10 As shown in Figure 2b , BALB/c c-FLIP L Tg thymocytes failed to upregulate the expression of CD69 and CD5, suggesting that thymic positive selection is impaired in the presence of c-FLIP L overexpression. To further facilitate the examination of positive selection, we established a TCR Tg system to specifically study the effect of the overexpression of c-FLIP L on the development of these cells. This was accomplished by breeding the I-A d -restricted DO11.10 TCR transgene, which is specific for a peptide from chicken ovalbumin (OVA) (amino acids 323-339; OVAp 323À339 ) 11, 12 onto BALB/c c-FLIP L Tg mice. Positive selection of the CD4 lineage was analyzed with the use of KJ1-26 anti-idiotypic mAb, which recognizes DO11.10 TCR. The analysis indicated that there Negative selection of thymocytes is a major mechanism of central tolerance. It is possible that the autoimmune lupus-like disorder observed in c-FLIP L Tg mice is because of the breakdown of central tolerance. To substantiate the role of c-FLIP L in thymic negative selection, we systemically administrated OVAp 323À339 peptide into OVA-specific TCR Tg DO11.10 and DO11.10.c-FLIP L Tg mice. Injection of OVAp 323À339 peptide into DO11.10 mice reduces both the percentage and the absolute number of immature Tg thymocytes. 13 We found that administration of OVAp 323À339 peptide did induce a deletion of DP thymocytes in NLCs in a dose-dependent manner, but this deletion was significantly The model of negative selection described above depends on the activation of exogenous TCR ligand in the system. To determine whether negative selection induced by endogenous antigens is also affected by the c-FLIP L transgene, we analyzed the repertoire of T cells reactive to endogenous mouse mammary tumor virus (MMTV) products presented on an I-E molecule. BALB/c mice have the integration of MMTVs (Mtv types 6, 8, and 9) in the genome and normally delete the viral super-antigen (VSAg)-reactive TCR Vb3-, 5-, 11-, and 12-positive T cells, whereas B6 mice fail to delete them because of the lack of MHC class II I-E molecules. 14, 15 As shown in Figure 2d , TCR Vb3-, 5-, 11-, and 12-positive cells were significantly deleted in thymi from NLCs, but this deletion was inhibited in BALB/c and not in B6 c-FLIP L Tg mice. Taken together, our data suggest that thymic negative selection is impaired in BALB/c mice overexpressing c-FLIP L . It is to be noted that DO11.10.c-FLIP L Tg mice developed a lupus-like syndrome at high incidence (Supplementary Figure S3 ), suggesting that disease development in these mice is possibly because of the expression of endogenous TCRs. Table 1 ). The ratio of T to B cells was abnormally increased in the spleens and lymph nodes, suggesting that enlarged secondary lymphoid tissues are not caused by expanded T-cell compartments of BALB/c c-FLIP L Tg mice. A significant fraction of CD4 þ and CD8 þ T cells from spleens and lymph nodes of BALB/c c-FLIP L Tg mice at 7 weeks of age expressed high levels of CD25, CD69, and CD44, but low levels of CD62L (Figure 3a and b), suggesting that they had recently been stimulated by antigens and were activated effector T cells. Therefore, splenomegaly and lymphoadenopathy observed in BALB/c c-FLIP L Tg mice are likely to be secondary to aberrant effector T-cell activation. In support of this notion, the percentages and numbers of B cells, granulocytes, macrophages, and DCs were significantly increased in BALB/c c-FLIP L Tg mice compared with those in their NLCs (Table 1) . We did not detect any B220 Figure S4a) , consistent with the earlier report. 6 In addition, we also found that expression of activation markers such as CD25, CD62L, CD69, and Fas was comparable between B6 c-FLIP L Tg T cells and their NLC T cells (Supplementary Figure S4b) . Therefore, development of autoimmunity requires a susceptible genetic background.
To Figure S5b) , in agreement with earlier reports. 6, 19 One of the principal responses of activated T cells is the production of cytokines. To test whether activated T cells from c-FLIP L Tg mice were able to secrete effector cytokines, we stimulated CD4 þ T cells from c-FLIP L Tg mice and NLCs with anti-CD3 or with anti-CD3 plus anti-CD28 for 72 h as described before, and the production of Th1, Th2, and Th17, as well as that of proinflammatory cytokines and chemokines, was measured by Cytokine 20-Plex in the supernatants collected. As shown in Figure 5d and Supplementary Figure  S5c , overexpression of c-FLIP L in T cells selectively led to a significant increase in the production of Th2 cytokines, especially IL-4, detected on TCR or TCR/CD28 stimulation, consistent with earlier reports. 20, 21 In support of this observation, serum IgG1 and IgE production was significantly elevated in BALB/c c-FLIP L Tg mice (data not shown). ) gene leads to the development of autoimmune arthritis or systemic autoimmunity as a result of altered thymic selection. 22, 23 To test whether overexpression of c-FLIP L interferes with proximal TCR signaling, we measured activation of Lck, ZAP-70, TCR-z, and LAT in thymocytes from BALB/c and B6 c-FLIP L Tg and NLC in response to TCR stimulation. Intriguingly, we found that although Lck Y394 phosphorylation was comparable between BALB/c c-FLIP L Tg and NLC thymocytes, phosphorylation of ZAP-70, TCR-z, and LAT was significantly reduced Figure  6a) . These observations suggest that overexpression of c-FLIP L may selectively impair the formation of TCR signalosome in a BALB/c background, which connects events on the plasma membrane to distal signaling cascades. 24 To test this idea, we assessed the assembly of TCR signalosome in thymocytes from BALB/c c-FLIP L Tg mice and their NLCs. As expected, TCR-induced signaling complex formation consisting of ZAP-70, TCR-z, LAT, and SH2-domain-containing leukocyte protein of 76 kDa (SLP-76) was defective in thymocytes overexpressing c-FLIP L in BALB/c mice (Figure 6b ). These data suggest that c-FLIP L overexpression may constrain ZAP-70 in the cytosol, thus inhibiting the translocation of ZAP-70 from the cytosol to the plasma membrane. To verify this possibility, we isolated cytosol and membrane fractions from BALB/c c-FLIP L Tg mice and NLCs before and after TCR stimulation by subcellular fractionation. 25 The amounts of ZAP-70, LAT, SLP-76, and phospholipase-gamma1 (PLC-g1) were significantly reduced in the membrane fraction from BALB/c c-FLIP L Tg thymocytes compared with that from NLC thymocytes after TCR stimulation (Figure 6c) . Therefore, our data support the notion that overexpressing c-FLIP L in T cells may impair the ZAP-70-mediated signaling pathway, thus attenuating TCR signaling responsible for thymic selection.
The signaling events downstream of the TCR have a critical role in positive and negative selection. To further determine the cause of the defect in positive and negative selection of BALB/c c-FLIP L Tg thymocytes, we assessed their responses to TCR stimulation. In particular, we examined mitogenactivated protein kinase (MAPK)-and NF-kB-pathways, as these TCR responses have an essential role in thymic selection [26] [27] [28] [29] We found a significant reduction in the phosphorylation of excellular signal-regulated kinase (ERK) and IkBa on TCR stimulation, whereas phosphorylation of c-Jun-NH 2 -terminal kinase (JNK) and p38 MAPK was comparable between BALB/c c-FLIP L Tg and NLC thymocytes in response to TCR stimulation ( Figure 7 ). These data suggest that c-FLIP L overexpression impairs TCR-induced activation of the ZAP-70-mediated signaling pathway, which subsequently results in an altered activation of ERK and NFkB responsible for thymic selection, thus eliciting lupus-like disease in BALB/c mice. In contrast, activation of MAPKs including ERK, JNK, and p38, as well as NF-kB, was comparable in the presence or absence of the c-FLIP L transgene in a B6 background (Supplementary Figure S6b) .
Discussion
In this study, we first report that BALB/c c-FLIP L Tg mice spontaneously develop lupus-like disease starting from 3 to 4 weeks of age, characterized by splenomegaly, lymphadeno- pathy, multiorgan infiltration including liver, lung, gastrointestine, heart, and salivary gland, proliferative glomerulonephritis with immune complex deposition, and high titers of auto-Abs (Figure 1 ). These features are clinically similar to human SLE patients. BALB/c c-FLIP L Tg T and B cells show activated phenotypes (Figure 3 ), suggesting that they are hyperactivated in vivo. The development of the disease requires CD4 þ T cells, and may be because of impaired thymic selection. Thus, the BALB/c c-FLIP L Tg strain provides evidence of a key role for c-FLIP L signals in the maintenance of immunological self-tolerance. Our data are consistent with reports that the elevated c-FLIP expression was observed in human T cells in patients with SLE, 30, 31 although the exact role of c-FLIP in SLE development in human remains to be elucidated.
The development of autoimmunity may result from a breakdown of central or peripheral tolerance. Autoreactive T cells are deleted in the thymus by negative selection. Recently, the defect in positive selection was reported to cause autoimmunity. 32 Moreover, a point mutation at the ZAP-70 (ZAP-70 W163C ) or LAT (LAT Y136F ) gene alters both positive and negative selection in the thymus, eliciting either autoimmune arthritis or systemic autoimmunity. 22, 23 In keeping with this, targeted disruption of Gads, as well as the deletion of the Gads binding site in SLP-76, impairs both positive and negative selection. 33 Moreover, in the Lcp2 twp strain, an ENU-induced mutation in a splice donor site reduces the amount of full-length mRNA encoding SLP-76 and promotes autoimmunity. 3 The failure to upregulate CD69 and CD5 in DP thymocytes of BALB/c c-FLIP L Tg mice suggests a defect in positive selection. Indeed, a similar reduction of CD4 SP thymocytes was also seen in DO11.10. c-FLIP L Tg mice (Figure 2c, upper panel) , supporting a defect in positive selection in these mice. Using two model systems, VSAg-mediated deletion and systemic administration of the OVA peptide to DO11.10.c-FLIP L Tg mice, we showed that thymic negative selection is also impaired in BALB/c mice overexpressing c-FLIP L (Figure 2c , middle and lower panels, and Figure 2d ). Taken together, our data indicate that c-FLIP L overexpression in T cells in a BALB/c background leads to altered thymic selection, resulting in positive selection of otherwise negatively selecting self-reactive T cells in the thymus.
Mechanistically, overexpressing c-FLIP L in T cells may impair the ZAP-70-mediated signaling pathway, thus attenuating the TCR signaling responsible for thymic selection. Consistent with the altered thymic selection in BALB/c c-FLIP L Tg mice, activation of ERK and NF-kB was impaired in c-FLIP L Tg thymocytes after TCR stimulation (Figure 7) . The attenuated activation of ERK and NF-kB would impair both positive and negative selections of T cells in BALB/c c-FLIP L Tg mice. 33, 34 As c-FLIP L may heterodimerize with caspase-8 on TCR stimulation, and caspase-8 may mediate NF-kB activation in a CARMA-1-dependent manner, 35, 36 it is presumed that TCR-induced c-FLIP L -caspase-8 heterodimer formation may interfere with the role of caspase-8 in NF-kB activation. However, c-FLIP L -mediated inhibition of NF-kB activation in the thymus remains to be further determined, as deficiency for caspase-8, CARMA-1, Bcl-10, and MALT-1 does not perturb thymic selection. 37, 38 It has been documented that c-FLIP L inhibits FasL-induced cell death. 39 However, c-FLIP L has also been suggested to be crucial for T-cell proliferation and differentiation [6] [7] [8] 21 As c-FLIP L is an endogenous inhibitor of caspase-8, it was expected that mice overexpressing c-FLIP L in T cells would lead to the development of lupus-like disease as seen in lpr mice. Unexpectedly, mice overexpressing c-FLIP L in T cells in a B6 background do not succumb to lupus-like syndrome. 6, 21, 39 In contrast to this, retrovirus-mediated overexpression of c-FLIP L in T and B cells blocks Fas-induced apoptosis of activated T and B cells, which leads to the production of auto-Abs and to the development of autoimmune diseases; 40 þ T cells in these mice (Figure 5b) .
The restrictive function of c-FLIP L further explains the requirement for genetic modifiers for the emergence of autoimmunity in mice overexpressing this molecule in T cells. Autoimmunity appears when multiple immunological pathways are perturbed. In general, single gene knockouts or transgenes that result in autoimmunity have pleiotropic effects on T-and B-cell function, as well as in antigen presentation. Specific genetic backgrounds may provide the additional co-activating components necessary for the development of autoimmune disease. This notion is supported by the fact that FcgRIIB À/À mice develop lupus-like autoimmune diseases in B6 but not in a BALB/c background, 41 suggesting that spontaneous autoimmune disease in FcgRIIB À/À mice results from strain-specific epistasis. Our data indeed support the notion that overexpression of c-FLIP L in T cells is not sufficient to trigger autoimmunity, and the development of a lupus-like autoimmune phenotype requires the trigger from a host genetic background. We believe that these two factors together affect the threshold for thymic selection that results in aberrant positive and negative selection in the thymus in BALB/c but not in B6 background. Indeed, thymic selection is intact in OT-II.c-FLIP L Tg mice (Supplementary Figure S2) . Moreover, the c-FLIP L transgene does not perturb proximal TCR signaling in the B6 background as seen in BALB/c c-FLIP L Tg mice (Supplementary Figure S6a) . Taken together, these data suggest that c-FLIP L overexpression in T cells may alter the threshold for T-cell activation in the BALB/c but not in the B6 strain required for thymic selection. The nature of these genetic factors that influence c-FLIP L function is currently under investigation.
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In conclusion, BALB/c c-FLIP L Tg mice spontaneously develop an autoimmune disorder showing many similarities to human SLE, providing a novel model of autoimmune disease in a strain-specific epistasis. The development of the disease is because of altered thymic selection. c-FLIP L is thus a susceptibility factor in the development of systemic autoimmune disease, contributing in a combinatorial manner through the presence of interacting genetic factors to the emergence of disease. Further study of BALB/c c-FLIP L Tg mice will improve our understanding of the complex network of signals that serve to maintain self-tolerance and will improve our insight into the genetic basis of autoimmune disease. Histopathology. Tissue specimens for histopathology were fixed in 4% paraformaldehyde (Fisher Scientific, Pittsburgh, PA, USA) or were snap frozen. Tissue sections (5 mm) were stained with hematoxylin and eosin (H&E) and evaluated by light microscopy. Immunohistochemical analysis on frozen kidney sections was performed on acetone-fixed sections. In brief, sections were blocked with 10% goat serum and, in some cases, with 0.1% Triton X-100, followed by fluorescein-conjugated goat anti-mouse IgG (Jackson Immunotech, West Grove, PA, USA) for 1 hr at room temperature. After washing, immunofluorescence analysis was performed using a Nikon Eclipse E600 microscope (Nikon, Meville, NY, USA).
Purification of T cells, B cells, and DCs. CD4
þ T cells were purified from the spleen by negative selection (490% CD4 þ ) (Miltenyi Biotec, Auburn, CA, USA). B cells were isolated (purity495% as determined by FACS analysis of B220 cell surface expression) using a B-cell isolation kit using negative selection (Miltenyi Biotec.). Contaminating T cells were o1%, as determined by CD3 staining. DCs were isolated from spleen by positive selection (490% DCs as determined by FACS analysis of CD11c) (Miltenyi Biotec.).
Cell activation and lysis. Thymocytes were maintained on ice in RPMI-1640 supplemented with 20 mM Hepes until stimulation. Quiescent thymocytes (4 Â 10 7 / ml) were stimulated with hamster anti-mouse CD3 mAb (1 mg/ml) on ice for 30 min, and washed in prewarmed medium, and crosslinked with anti-hamster IgG (10 mg/ ml) for various times. The cells were lysed in 1% Triton X-100 lysis or in 0.5% NP-40 lysis buffer as indicated.
Adoptive transfer. CD4 þ T cells (5 Â 10 6 ) and B cells ( 10 7 ) from BALB/c c-FLIP L Tg mice and NLCs at 2 weeks of age were i.v. injected into Rag-1 À/À recipients (n ¼ 5) with different combinations as indicated. The mice were killed 7 weeks later, and serum anti-dsDNA Abs were determined by ELISA. Different organs were collected for histopathological analysis.
Detection of auto-Abs by ELISA. Anti-nuclear Abs (ANA) were detected by ELISA. Auto-Abs to double-stranded DNA (dsDNA), ssDNA, and nuclei were determined by ELISA as described earlier. 42 Flow cytometry. The following Abs (Pharmingen, San Diego, CA, USA) were used: anti-CD4 (clone GK1.5), anti-CD8 (53-6.7), KJ1-26, anti-Vb3, anti-Vb5, anti-Vb11, anti-Vb12, anti-B7-1 (16-10A1), anti-B7-2(GL1), and anti-B-220 (RA3-6B2) for lineage markers; anti-CD69 (H1.2F3), anti-CD44 (IM7), anti-CD62L (MEL-14), anti-Fas (Jo2), anti-CD5 (53-7.3), and anti-CD25 (PC81) for activation markers. Acquisition of samples was performed on a FACScan flow cytometer, and data were analyzed using FlowJo software V.4.4.3 (Tree Star Inc., Ashland, OR, USA).
In vivo administration of OVAp 323À339 . DO11.10 and DO11.10.c-FLIP L Tg or OT-II and OT-II.c-FLIP L Tg mice (2 weeks of age) were injected intraperitoneally with PBS or OVAp 323À339 once a day at doses of 30 mg or 300 mg/mouse. Mice were killed after 72 h, and their thymi were removed for analysis.
Assays for cell proliferation and apoptosis. T cells were stimulated with anti-CD3 or anti-CD3 and anti-CD28 for the indicated times. Proliferation was assayed by measuring [ Cytokine assay by luminex. Mouse cytokine 20-plex assay kits (Invitrogen, Carlsbad, CA, USA) were used to measure the concentrations of cytokines in the supernatants collected from T-cell cultures according to the manufacturer's instruction. Concentrations of analyte in samples were determined by interpolation from 20 individual standard curves, using the five-parameter curve fitting provided in Bio-Plex Manager software version 3.0 (Bio-Rad, Hercules, CA, USA). Subcellular fractionation. Thymocytes (10 8 ) were resuspended and lysed by brief sonication in ice-cold 10 mM Tris, pH 7.4, 10 mM KCl, 1.5 mM MgCl 2 and 2 mM EGTA hypotonic buffer containing the above-described mixture of protease and phosphatase inhibitors (buffer A). Lysates were adjusted to 150 mM NaCl, centrifuged to remove nuclei and debris, and particulate membrane-containing (P100) and soluble cytoplasm-containing (S100) fractions were separated by differential centrifugation for 30 min at 100 000 g. 43 Membrane fractions were washed with ice-cold buffer A, and solubilized by sonication in buffer A supplemented with 150 mM NaCl and 1% Triton X-100.
Immunoprecipitations of cellular proteins. Precleared postnuclear fractions obtained from 4 Â 10 7 cells were normalized for protein concentration levels and immunoprecipitated (3 h at 4 1C) with the specific polyclonal Abs or control isotype-matched preimmune Ig precoupled to 30 ml of protein A-Sepharose CL-4B (GE Healthcares Systems, Piscataway, NJ, USA). This was followed by four washes of the precipitates with ice-cold lysis buffer.
Western blot analysis. The thymocyte lysates from NLCs and BALB/c c-FLIP L Tg mice were blotted with phospho-Abs against Lck (Y394), ZAP-70 (Y493), LAT (Y191), PLC-g1 (Y783), ERK (T202/Y204), JNK (T183/Y185), p38 MAPK (T180/Y182), or IkB(S32) (Cell Signaling Technology, Inc., Beverly, MA, USA), and anti-actin (Sigma-Aldrich). Precipitated proteins or the membrane and cytosol fractions were solubilized in 2 Â Laemmli sample buffer-containing 2-ME, 20 mM EDTA, and 2 mM Na 3 VO 4 , resolved by SDS-PAGE under reducing conditions, transferred to immobilon (Millipore, Bedford, MA, USA) or nitrocellulose (Schleicher & Schuell, Keene, NH, USA) membranes, and immunoblotted with the indicated Abs.
